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ABSTRACT
Introduction: This case report presents the
pressure-lowering effect of transluminal fistula
occlusion in a patient suffering from secondary
glaucoma due to carotid cavernous fistula
(CCF).
Case Report: A 76-year-old Caucasian woman
presented with dilated epibulbar vessels with
elevated intraocular pressure (IOP,[30 mmHg)
as well as glaucomatous excavations of the optic
disc in both eyes. Cerebral digital subtraction
angiography revealed a CCF with bilateral
orbital communication. Preoperative diurnal
pressure profiling showed an average IOP of
25.8 mmHg (right eye) and 26.6 mmHg (left
eye). Transluminal intervention and fistula
occlusion led to a decrease in IOP of about
9 mmHg. A post-operative oculomotor nerve
palsy regressed spontaneously.
Conclusion: Secondary glaucoma due to CCF
might be affected by fistula occlusion.
Therefore, it should be considered before any
surgical glaucoma interventions are performed.
Diurnal pressure profiling is an effective tool for
monitoring therapeutic success.
Keywords: Carotid cavernous fistula; Diurnal
pressure monitoring; Embolization therapy;
Secondary glaucoma
INTRODUCTION
Intraocular pressure (IOP) is regulated via a
constant equilibrium of intraocular fluid
production and efflux. The interaction
between intra- and periocular vessels and
their state of filling plays a major role in the
pathogenesis of secondary open-angle
glaucoma. Fluctuations in the pressure ratios
of these vessels directly affect IOP [1, 2]. The
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normal episcleral venous pressure is about 8 to
10 mmHg. Once the venous pressure has
reached the level of the IOP, an isotonic
increase in IOP develops with additional
increases in venous pressure. Moreover, an
increase of pulsatile pressure fluctuations can
be observed. With congestion-caused
secondary glaucoma, the intraocular fluid
increases, including both the intravasal and
extravasal volumes. The autoregulatory
processes of pressure equalization become
disrupted and are, therefore, difficult to target
with drug therapy. To determine the cause, the
following conditions are to be considered:
congenital vascular malformations (e.g.,
Sturge–Weber syndrome), orbital or
intracranial arteriovenous fistulas, idiopathic
forms (so-called idiopathic elevated episcleral
venous pressure or Radius–Maumenee
syndrome) or thrombotic events within the
perfusion area of the large venous vessels in
the head and neck area (intracranially, e.g.,
cavernous sinus; extracranially, e.g., jugular
vein, superior vena cava, or pulmonary vein)
[3–5]. Aside from glaucomatous changes, there
are frequently congested epibulbar vessels,
chemosis, eyelid edema and orbital bruits.
Gonioscopy typically shows an open chamber
angle, frequently with a blood-filled Schlemm’s
canal. Drug therapy is mostly inefficient and
surgical intervention is necessary.
Complications such as choroidal effusion as
well as expulsive bleeding arise frequently in
this condition [3, 5].
All procedures followed were in
accordance with the ethical standards of the
responsible committee on human
experimentation (institutional and national)
and with the Helsinki Declaration of 1964, as
revised in 2013. Informed consent was
obtained from the patient for being
included in the study.
CASE REPORT
A 76-year-old female patient was referred to our
clinic for consultation with eye reddening and
glaucoma ‘‘resistant to drug therapy’’. Despite
topical triple therapy, the IOP was above
30 mmHg on both sides. On an outpatient
basis, an Nd:YAG laser iridotomy had been
performed on both eyes, which showed no
effect on IOP. In general, the patient suffered
from arterial hypertension and atrial
fibrillation. Initially, these general symptoms
were not identified.
With a more focused interview, she reported
tinnitus that persisted for the previous 6 years.
The IOP was in need of treatment for 3 years.
For the past year, the patient noticed an
increasing reddening of both eyes. The patient
could not recall past trauma. Connective tissue
weakness had not been reported.
Ophthalmological examination showed a
best corrected visual acuity of 1.0 (Snellen
charts) on both sides. The IOP was 27 mmHg
in both eyes. Slit lamp examination showed
markedly dilated epibulbar vessels (Fig. 1a).
Intraocular findings included bilateral iris
hyperemia (Fig. 1b) as well as glaucomatous
papillae (progressed on the right side, beginning
on the left side; Fig. 1c). There were progressive
glaucomatous vision field defects. The patient
was admitted for in-patient glaucoma
diagnostics (i.e., diurnal pressure profiling
(DPP) including night measurements using
Goldmann applanation tonometry), as well as
a digital subtraction angiography (DSA). The
DPP showed pressure values of 23 to 28 mmHg
on the right side (average 25.8 mmHg) and 24
to 29 mmHg on the left side (average
26.6 mmHg). The DSA results showed a
complex situation with two arteriovenous
shunts within the area of the cavernous sinus,
as well as an arteriovenous fistula between the
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left external carotid artery and the jugular vein.
The carotid cavernous fistula (CCF)
corresponded to a Barrow type B (Fig. 2).
Following an unsuccessful attempt at
conservative therapy by manual compression
treatment, a neuroradiological intervention was
scheduled. In the meantime, the patient
received systemic carboanhydrase inhibitors.
Transluminal embolization of the CCF was
performed after failure of conservative
therapy attempts. Post-operatively, a
cavernous sinus thrombosis occurred, with
paresis of the right-side oculomotor nerve
(complete, inside and outside). Due to a
hemodynamically relevant bleeding within
the puncture area (femoral artery), an
Fig. 1 Ophthalmological ﬁndings. a Dilated epibulbar vessels. b Congested vessels of the iris. c Fundus photograph of the
papillae (top right eye, bottom left eye)
Fig. 2 Radiological ﬁndings (DSA). a Lateral view (ﬁstula location labeled). b A–P view (retrograde ﬁlling of the anterior
intercavernous sinus labeled). DSA digital subtraction angiography
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intervention performed by the vascular
surgery department became necessary.
Ptosis and double vision showed rapid
improvement. After 4 weeks, the patient was
free of double vision. A discrete ptosis and an
anisocoria remained. Six months after surgery
of the CCF, a DPP was performed again.
Although topical therapy only consisted of
two anti-glaucomatous drugs, the IOP was the
following: on the right side, 14 to 20 mmHg
(average 17.0 mmHg); on the left side, 15 to
20 mmHg (average 17.6 mmHg). Thus, the IOP
was lowered on the right side by a mean of
8.8 mmHg, and on the left side, by a mean of
9.0 mmHg. Three months later the DPP showed
a mean pressure of 15.0 mmHg on the right side
and 14.6 mmHg on the left side (Fig. 3).
Threshold perimetry and measurement of the
retinal nerve fiber layer did not indicate a
disease progression.
DISCUSSION
CCF produces an intracranial arteriovenous
shunt [6, 7]. Typical clinical signs and the
emergence of secondary glaucoma should lead
an ophthalmologist to suspect CCF. An imaging
procedure (i.e., DSA) serves to ascertain the
diagnosis. CCF can be classified according to
cause (traumatic vs. spontaneous),
hemodynamics (high flow vs. low flow) and
anatomy (direct vs. indirect). Clinically,
classification oriented toward anatomy (i.e.,
Barrow type A–D) has been established [6–8].
The cavernous sinus is a duplicature of the
dura mater. It contains numerous pathways of
conduction (i.e., cranial nerves III, IV, V1, V2
and VI, as well as the internal carotid artery).
The venous connection to the orbita is provided
by the superior ophthalmic vein. In CCF, there
is more or less pronounced arterialization of this
vessel, with corresponding reversal of flow and
congestion [1, 3, 4, 9]. The consequence is an
increase in episcleral venous pressure. This is
transferred from the aqueous veins to the
collecting vessels and Schlemm’s canal and,
thus, leads to an increase in IOP. Typical clinical
signs may occur; i.e., red eye, pulsating
exophthalmos and secondary glaucoma [7].
However, depending upon hemodynamics,
symptoms may vary widely. High-flow (direct)
fistulas usually occur acutely in connection
with a trauma or rupture of an intracavernous
aneurysm of the internal carotid artery. Most
noticeable is a solid chemosis and an
exophthalmos. Due to damage to the vasa
nervorum, pareses may occur [6]. Dependent
on the findings (e.g., impairment of visual
acuity, IOP increase [40 mmHg, and cortical
drainage path), there may be an emergency
indication for fistula closure [9]. A low-flow
(indirect) fistula results from a remodeling after
cavernous sinus thrombosis with slowly
developing arteriovenous shunts between
branches of the internal carotid artery and the
cavernous sinus. Usually older patients are
affected. Pulsatile exophthalmos does not
occur. Symptoms develop subtly, in which
approximately one-third of the cases develop
secondary glaucoma [3, 6, 9, 10]. Nevertheless,
not every fistula requires treatment. However,
regular ophthalmological monitoring is
mandatory, as secondary glaucoma and vision
impairments may develop subtly [3].
A retrospective multicenter investigation
reports 14 eyes of 43 patients with CCF
showing ocular manifestations [10]. Patients
were recruited over 16 years. Of these about
two-thirds developed secondary glaucoma. The
most common symptom was conjunctival
hyperemia (92.9%). Surgical fistula occlusion
was done in only 4 of 9 cases. Here, three eyes
had a good outcome of IOP control. If CCF
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closed spontaneously it was also predictive for
good IOP outcome. Generally, anti-glaucoma
treatments were more effective in eyes with CCF
closure [10]. Therefore, these results may also
focus on fistula closure as the primary therapy.
Currently, neuroradiological transluminal
intervention is the therapy of choice. Over
90% of the fistulas can thereby be treated
successfully [9]. Among the availabilities are
fluid embolisates, coils or detachable balloons
[9–12]. Arterial or venous access is possible and
interdisciplinary approaches are to be favored
[12, 13]. Aside from a very low immediate risks
(e.g., stroke), thrombosis of the cavernous sinus
may occur after intervention, as in the reported
case. To reduce the risk for such complications,
temporary therapeutic heparinization is
indicated [14].
Patient support requires an interdisciplinary
concept. For indication and evaluation,
Fig. 3 IOP proﬁles compared before and after closure of the ﬁstula. Time between measurements was 3 h. DPP diurnal
pressure proﬁle, IOP intraocular pressure, OD right eye, OS left eye, t time of measurement
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standardized examinations are necessary. The
clinical symptoms should be documented as
well if possible (e.g., photographic
documentation). For glaucoma diagnostics and
post-operative evaluation, 24-h-intraocular
pressure measurement is appropriate [15, 16].
Ideally and for improved reliability, this should
be performed over 48 h or longer, in particular if
vascular factors are pathogenetically involved
[16, 17].
CONCLUSION
Intracranial arteriovenous shunts are not a
homogeneous clinical entity and may manifest
themselves in various forms. An intractable
secondary glaucoma is a frequent complication
and represents an indication for the treatment
of CCF. Thereby, a clear pressure-lowering effect
can be obtained. Fistula closure should thus
take place before any surgical glaucoma
interventions.
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